For those interested in making contributions in Dr. Schrier’s memory:
Select School of Medicine, and under
“Special Instructions/Other Designation”, write, “Stanley Schrier Memorial Fund”.
Alternatively, please make gifts payable to: Stanford University. On the Memo line or an accompanying note, please indicate “Stanley Schrier Memorial Fund”. Please submit your donation to: Development Services, P.O. Box 20466, Stanford, CA 94309-0466
See Below for other publications
Hematology Welcomes Dr. May Chien
Clinical Assistant Professor of Medicine, Hematology and of Pediatrics
Dr. May Chien is a hematologist trained in internal medicine and pediatrics. Her clinical interests lie in inherited blood disorders which are diagnosed in children but extend into adulthood, as well as hemostasis and thrombosis. Her research interests include gene therapy for hemophilia and understanding the pathophysiology of immune thrombocytopenia.
Dr. Chien received her BA in Biology at Amherst College, MA and attended University of Southern California Keck School of Medicine. She stayed at USC to complete a residency in combined Internal Medicine and Pediatrics at USC and served as chief resident. She trained in pediatric hematology/oncology and adult hematology at Stanford University, where she is now a clinical assistant professor in the Departments of Internal Medicine and Pediatrics.
Message from the Chief
Welcome to the Stanford Division of Hematology, a dynamic center for basic and translational research, clinical trials, patient care, and teaching. Our physicians, scientists, staff, and trainees collaborate to advance the understanding and treatment of hematologic disorders, all with the goal of improving outcomes for patients with these diseases. In pursuit of this objective, we engage with the broader Stanford community to bring innovation to our efforts.
Over the last 20 years, multiple novel therapies have resulted in significant clinical advances for hematologic diseases, and Stanford investigators have played key roles in their development, including imatinib for CML, ibrutinib for CLL, midostaurin for mast cell disease, and many others. Our clinicians have expertise in a broad range of hematologic disorders including acute and chronic leukemias, myeloproliferative neoplasms, myelodysplastic syndromes, multiple myeloma, amyloidosis, thrombotic diseases, coagulation disorders, and general hematology.
The basic and translational research efforts of the division have led to fundamental discoveries in areas as diverse as leukemia & stem cells, genomics, thrombosis, telomere & cancer biology, and the microbiome. Our passionate faculty members have mentored and trained leaders in the field of hematology and are committed to attract the next generation of leading physicians and research scientists. We invite you to learn more about us through our website.